13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001444043
Total reported value
$1.1B
$1.1B
36 檔
192.1%
The Q1 2024 SEC filing reveals that Camber Capital Management LP held a total portfolio value of $1.1B, covering 36 public equity positions.
During Q1 2024, Camber Capital Management LP's portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 28.20% | — | +10.00% | |
| 2 | ZBH | Zimmer Biomet Holdings Inc | Stock-Healthcare | 6.23% | — | — | |
| 3 | UHS | Universal Health Services-b | Stock-Healthcare | 5.59% | — | -33.16% | |
| 4 | BAX | Baxter International Inc | Stock-Healthcare | 5.24% | — | — | |
| 5 | THC | Tenet Healthcare CORP | Stock-Healthcare | 4.89% | — | -49.27% | |
| 6 | VTRS | Viatris Inc | Stock-Healthcare | 4.76% | — | -12.16% | |
| 7 | WBA | Walgreens Boots Alliance Inc | Stock-Other | 4.15% | — | +11.43% | |
| 8 | MYGN | Myriad Genetics Inc | Stock-Other | 3.99% | — | — | |
| 9 | MDT | Medtronic plc | Stock-Healthcare | 3.95% | — | — | |
| 10 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 3.39% | — | +70.37% | |
| 11 | GMED | Globus Medical Inc - A | Stock-Healthcare | 3.29% | — | +11.11% | |
| 12 | PTCT | Ptc Therapeutics Inc | Stock-Healthcare | 2.85% | — | — | |
| 13 | SEM | Select Medical Holdings CORP | Stock-Other | 2.51% | — | — | |
| 14 | BKD | Brookdale Senior Living Inc | Stock-Other | 2.51% | — | — | |
| 15 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 2.29% | — | — | |
| 16 | BIIB | Biogen Inc | Stock-Healthcare | 2.11% | — | — | |
| 17 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 1.86% | — | -26.88% | |
| 18 | PFE | Pfizer Inc | Stock-Healthcare | 1.70% | — | -36.22% | |
| 19 | ZIMV | Zimvie Inc | Stock-Other | 1.31% | — | — | |
| 20 | QGEN | Qiagen N.V. | Stock-Healthcare | 1.27% | — | — | |
| 21 | PRGO | Perrigo Company plc | Stock-Healthcare | 1.20% | — | -17.84% | |
| 22 | COLL | Collegium Pharmaceutical Inc | Stock-Other | 0.81% | — | -18.77% | |
| 23 | DNLI | Denali Therapeutics Inc | Stock-Other | 0.75% | — | — | |
| 24 | HLF | Herbalife Ltd. | Stock-Other | 0.74% | — | +50.00% | |
| 25 | OSUR | Orasure Technologies Inc | Stock-Other | 0.64% | — | — | |
| 26 | BKD 7 11-15-25Bond | Brookdale Senior Living | Bond | 0.56% | — | — | |
| 27 | REPL | Replimune Group Inc | Stock-Other | 0.55% | — | +175.00% | |
| 28 | BMRN | Biomarin Pharmaceutical Inc | Stock-Healthcare | 0.54% | — | — | |
| 29 | PTON | Peloton Interactive Inc-a | Stock-Consumer Disc | 0.47% | — | — | |
| 30 | INGN | Inogen Inc | Stock-Other | 0.40% | — | — | |
| 31 | SKIN | Skinhealth Systems Inc | Stock-Other | 0.38% | — | — | |
| 32 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 0.27% | — | — | |
| 33 | TBPH | Theravance Biopharma, Inc. | Stock-Other | 0.22% | — | — | |
| 34 | PBYI | Puma Biotechnology Inc | Stock-Other | 0.21% | — | -41.18% | |
| 35 | ✓ | Curevac N V | Stock-Other | 0.13% | — | — | |
| 36 | GMAB | Genmab A/s -sp Adr | Stock-Other | 0.04% | — | — |
According to official SEC Form 13F filings, Camber Capital Management LP reported a total U.S. public equity portfolio value of $1.1B across 36 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including SPY, ZBH, UHS) accounted for 192.1% of total reported equity market value during Q1 2024.
During Q1 2024, Camber Capital Management LP's top holdings by market value included SPY (28.2%)、ZBH (6.2%)、UHS (5.6%). The largest single position, SPY, represented 28.2% of total portfolio value.
In Q1 2024, Camber Capital Management LP made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.